Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease

April 2013

Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease.

It's for patients with pituitary tumors...when surgery isn't an option or isn't effective.

It's an injectable somatostatin analogue that suppresses the release of ACTH (adrenocorticotropic hormone).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote